The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study
Open accessAbstract
BACKGROUND: Removal of adenomas reduces colorectal cancer incidence and mortality; however, the benefit of surveillance colonoscopy on colorectal cancer risk remains unclear. We examined heterogeneity in colorectal cancer incidence in intermediate-risk patients and the effect of surveillance on colorectal cancer incidence. METHODS: We did this retrospective, multicentre, cohort study using routine lower gastrointestinal endoscopy and pathology data from patients who, after baseline colonoscopy and polypectomy, were diagnosed with intermediate-risk adenomas mostly (>99%) between Jan 1, 1990, and Dec 31, 2010, at 17 hospitals in the UK. These patients are currently offered surveillance colonoscopy at intervals of 3 years. Patients were followed up through to Dec 31, 2014.We assessed the effect of surveillance on colorectal cancer incidence using Cox regression with adjustment for patient, procedural, and polyp characteristics. We defined lower-risk and higher-risk subgroups on the basis of polyp and procedural characteristics identified as colorectal cancer risk factors. We estimated colorectal cancer incidence and standardised incidence ratios (SIRs) using as standard the general population of England in 2007. This trial is registered, number ISRCTN15213649. FINDINGS: 253 798 patients who underwent colonic endoscopy were identified, of whom 11 944 with intermediate-risk adenomas were included in this analysis. After a median follow-up of 7·9 years (IQR 5·6-11·1), 210 colorectal cancers were diagnosed. 5019 (42%) patients did not attend surveillance and 6925 (58%) attended one or more surveillance visits. Compared to no surveillance, one or two surveillance visits were associated with a significant reduction in colorectal cancer incidence rate (adjusted hazard ratio 0·57, 95% CI 0·40-0·80 for one visit; 0·51, 0·31-0·84 for two visits). Without surveillance, colorectal cancer incidence in patients with a suboptimal quality colonoscopy, proximal polyps, or a high-grade or large adenoma (≥20 mm) at baseline (8865 [74%] patients) was significantly higher than in the general population (SIR 1·30, 95% CI 1·06-1·57). By contrast, in patients without these features, colorectal cancer incidence was lower than that of the general population (SIR 0·51, 95% CI 0·29-0·84). INTERPRETATION: Colonoscopy surveillance benefits most patients with intermediate-risk adenomas. However, some patients are already at low risk after baseline colonoscopy and the value of surveillance for them is unclear. FUNDING: National Institute for Health Research Health Technology Assessment, Cancer Research UK.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cited by
Hassan, C., Antonelli, G., Dumonceau, J.-M., Regula, J., Bretthauer, M., Chaussade, S., Dekker, E., Ferlitsch, M., Gimeno-Garcia, A., Jover, R., et al. (2020) · Endoscopy · doi:10.1055/a-1185-3109 · Cited by 515
Gupta, S., Lieberman, D., Anderson, J. C., Burke, C. A., Dominitz, J. A., Kaltenbach, T., Robertson, D. J., Shaukat, A., Syngal, S., & Rex, D. K. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.10.026 · Cited by 461
Rutter, M. D., East, J., Rees, C. J., Cripps, N., Docherty, J., Dolwani, S., Kaye, P. V., Monahan, K. J., Novelli, M. R., Plumb, A., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319858 · Cited by 380
Self-citationTesta, U., Pelosi, E., & Castelli, G. (2018) · Medical Sciences · doi:10.3390/medsci6020031 · Cited by 374
Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications
Lega, I. C., & Lipscombe, L. L. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz014 · Cited by 364
Metadata
- Authors
- Atkin, W., Wooldrage, K., Brenner, A., Martin, J., Shah, U., Perera, S., Lucas, F., Brown, J. P., Kralj-Hans, I., Greliak, P., Pack, K., Wood, J., Thomson, A., Veitch, A., Duffy, S. W., & Cross, A. J.
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 18
- Issue
- 6
- Pages
- 823-834
- ISSN
- 1470-2045 (ISSN-L)
- OpenAlex
- W2608030142
- Cited by
- 249
- References
- 1
- FWCI
- 8.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study. https://app.cochat.ai/papers/10.1016/s1470-2045(17)30187-0
- The paper
- Atkin, W., Wooldrage, K., Brenner, A., Martin, J., Shah, U., Perera, S., Lucas, F., Brown, J. P., Kralj-Hans, I., Greliak, P., Pack, K., Wood, J., Thomson, A., Veitch, A., Duffy, S. W., & Cross, A. J. (2017). Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(17)30187-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.